Pentobarbital will reduce the extent or outcome of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The result of barbiturates around the metabolism of phenytoin seems to become variable. Some investigators report an accelerating outcome, while others report no outcome. As the influence of barbiturates to the metabolism of phenytoin https://henryz221vky9.shoutmyblog.com/profile